Literature DB >> 12687673

Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome.

Johan L K Van Hove1, Ron A Wevers, Johan Van Cleemput, Philippe Moerman, Raf Sciot, Gert Matthijs, Els Schollen, Jan G N de Jong, William F Carey, Viv Muller, Cath Nicholls, Kelly Perkins, John J Hopwood.   

Abstract

Sanfilippo A syndrome, mucopolysaccharidosis type IIIA, is caused by a deficiency of heparan sulphamidase activity, and usually presents in childhood with neurodegeneration leading to death in teenage years. Visceral symptoms are limited to coarsening and diarrhea. We now describe an adult patient who presented with cardiomyopathy. At age 45 years she had hypertension, and the next year she developed a progressively worsening cardiomyopathy with prominent apical hypertrophy and atrial fibrillation. At age 53, she had severe concentric hypertrophic nonobstructive cardiomyopathy in both ventricles. There was no coarsening of features. Neurologic function, skeleton, cornea, liver, and spleen were normal. Percutaneous endomyocardial biopsy showed ballooned cardiomyocytes with storage vacuoles, containing acid mucopolysaccharides. Leucocytes, uterus, and brain biopsy did not show this storage material. There was a slight increase in total urine mucopolysaccharides, with an increased proportion of heparan sulfates. Heparan sulphamidase activity was deficient in leukocytes and heparan sulphamidase protein and activity were reduced in cultured fibroblasts. No mutations were identified after sequencing of the heparan sulphamidase gene at the cDNA and the genomic level. This new clinical presentation expands the clinical spectrum of Sanfilippo A syndrome to include a primary visceral presentation of cardiomyopathy without neurologic symptoms in the adult. The late onset may be related to the residual heparan sulphamidase activity. The genetic basis of this new variant is still unclear. Physicians evaluating adults must remain aware of possible new adult presentations of storage conditions. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687673     DOI: 10.1002/ajmg.a.20068

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.

Authors:  Adeline A Lau; Barbara M King; Carly L Thorsen; Sofia Hassiotis; Helen Beard; Paul J Trim; Lauren S Whyte; Sarah J Tamang; Stephen K Duplock; Marten F Snel; John J Hopwood; Kim M Hemsley
Journal:  J Inherit Metab Dis       Date:  2017-04-27       Impact factor: 4.982

2.  Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology.

Authors:  David E Sleat; Lin Ding; Shudan Wang; Caifeng Zhao; Yanhong Wang; Winnie Xin; Haiyan Zheng; Dirk F Moore; Katherine B Sims; Peter Lobel
Journal:  Mol Cell Proteomics       Date:  2009-04-20       Impact factor: 5.911

3.  Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report.

Authors:  Erlane Marques Ribeiro; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Carlos Antônio Bruno da Silva; Ida Vanessa Schwartz
Journal:  Mol Genet Metab Rep       Date:  2014-09-29

4.  The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype.

Authors:  Stephanie C M Nijmeijer; L Ingeborg van den Born; Anneke J A Kievit; Karolina M Stepien; Janneke Langendonk; Jan Pieter Marchal; Susanne Roosing; Frits A Wijburg; Margreet A E M Wagenmakers
Journal:  Orphanet J Rare Dis       Date:  2019-11-12       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.